Cargando…
Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis
This study aims to provide practical recommendations on prophylaxis for infection in pediatric patients with immune-mediated rheumatic diseases receiving/scheduled to receive immunosuppressive therapy. A qualitative approach was applied. A narrative literature review was performed via Medline. Prima...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570166/ https://www.ncbi.nlm.nih.gov/pubmed/37439850 http://dx.doi.org/10.1007/s00431-023-05080-3 |
_version_ | 1785119702150807552 |
---|---|
author | Clemente Garulo, Daniel Núñez-Cuadros, Esmeralda Camacho Lovillo, Marisol Calzada-Hernández, Joan Guillén Martín, Sara Fernández Silveira, Laura Lirola Cruz, María José Tagarro, Alfredo Alcobendas Rueda, Rosa María López López, Agustín Satrustegi Aritziturri, Miren Calvo, Cristina |
author_facet | Clemente Garulo, Daniel Núñez-Cuadros, Esmeralda Camacho Lovillo, Marisol Calzada-Hernández, Joan Guillén Martín, Sara Fernández Silveira, Laura Lirola Cruz, María José Tagarro, Alfredo Alcobendas Rueda, Rosa María López López, Agustín Satrustegi Aritziturri, Miren Calvo, Cristina |
author_sort | Clemente Garulo, Daniel |
collection | PubMed |
description | This study aims to provide practical recommendations on prophylaxis for infection in pediatric patients with immune-mediated rheumatic diseases receiving/scheduled to receive immunosuppressive therapy. A qualitative approach was applied. A narrative literature review was performed via Medline. Primary searches were conducted using MeSH terms and free text to identify articles that analyzed data on infections and vaccinations in pediatric patients with immune-mediated rheumatic diseases receiving immunosuppressive therapy. The results were presented and discussed in a nominal group meeting comprising a committee of 12 pediatric rheumatologists from the Prevention and Treatment of Infections Working Group of the Spanish Society of Pediatric Rheumatology. Several recommendations were generated. A consensus procedure was implemented via a Delphi process that was extended to members of the Spanish Society of Pediatric Rheumatology and the Vaccine Advisory Committee of the Spanish Association of Pediatrics. Participants produced a score ranging from 0 (completely disagree) to 10 (completely agree). Agreement was considered to have been reached if at least 70% of participants voted ≥ 7. The literature review included more than 400 articles. Overall, 63 recommendations were generated (23 on infection prophylaxis) and voted by 59 pediatric rheumatologists and other pediatric specialists, all of whom achieved the pre-established level of agreement. The recommendations on prophylaxis of infection cover vaccination and prophylaxis against varicella zoster virus, tuberculosis, Pneumocystis jiroveccii, and invasive fungal infections in pediatric patients with immune-mediated rheumatic diseases receiving/scheduled to receive immunosuppressive therapy. Conclusion: Based on current evidence and a Delphi process, we provided consensus and updated recommendations on prophylaxis and treatment of infections to guide those caring for pediatric rheumatology patients. |
format | Online Article Text |
id | pubmed-10570166 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-105701662023-10-14 Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis Clemente Garulo, Daniel Núñez-Cuadros, Esmeralda Camacho Lovillo, Marisol Calzada-Hernández, Joan Guillén Martín, Sara Fernández Silveira, Laura Lirola Cruz, María José Tagarro, Alfredo Alcobendas Rueda, Rosa María López López, Agustín Satrustegi Aritziturri, Miren Calvo, Cristina Eur J Pediatr Guideline This study aims to provide practical recommendations on prophylaxis for infection in pediatric patients with immune-mediated rheumatic diseases receiving/scheduled to receive immunosuppressive therapy. A qualitative approach was applied. A narrative literature review was performed via Medline. Primary searches were conducted using MeSH terms and free text to identify articles that analyzed data on infections and vaccinations in pediatric patients with immune-mediated rheumatic diseases receiving immunosuppressive therapy. The results were presented and discussed in a nominal group meeting comprising a committee of 12 pediatric rheumatologists from the Prevention and Treatment of Infections Working Group of the Spanish Society of Pediatric Rheumatology. Several recommendations were generated. A consensus procedure was implemented via a Delphi process that was extended to members of the Spanish Society of Pediatric Rheumatology and the Vaccine Advisory Committee of the Spanish Association of Pediatrics. Participants produced a score ranging from 0 (completely disagree) to 10 (completely agree). Agreement was considered to have been reached if at least 70% of participants voted ≥ 7. The literature review included more than 400 articles. Overall, 63 recommendations were generated (23 on infection prophylaxis) and voted by 59 pediatric rheumatologists and other pediatric specialists, all of whom achieved the pre-established level of agreement. The recommendations on prophylaxis of infection cover vaccination and prophylaxis against varicella zoster virus, tuberculosis, Pneumocystis jiroveccii, and invasive fungal infections in pediatric patients with immune-mediated rheumatic diseases receiving/scheduled to receive immunosuppressive therapy. Conclusion: Based on current evidence and a Delphi process, we provided consensus and updated recommendations on prophylaxis and treatment of infections to guide those caring for pediatric rheumatology patients. Springer Berlin Heidelberg 2023-07-13 2023 /pmc/articles/PMC10570166/ /pubmed/37439850 http://dx.doi.org/10.1007/s00431-023-05080-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Guideline Clemente Garulo, Daniel Núñez-Cuadros, Esmeralda Camacho Lovillo, Marisol Calzada-Hernández, Joan Guillén Martín, Sara Fernández Silveira, Laura Lirola Cruz, María José Tagarro, Alfredo Alcobendas Rueda, Rosa María López López, Agustín Satrustegi Aritziturri, Miren Calvo, Cristina Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis |
title | Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis |
title_full | Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis |
title_fullStr | Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis |
title_full_unstemmed | Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis |
title_short | Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis |
title_sort | position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis |
topic | Guideline |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570166/ https://www.ncbi.nlm.nih.gov/pubmed/37439850 http://dx.doi.org/10.1007/s00431-023-05080-3 |
work_keys_str_mv | AT clementegarulodaniel positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis AT nunezcuadrosesmeralda positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis AT camacholovillomarisol positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis AT calzadahernandezjoan positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis AT guillenmartinsara positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis AT fernandezsilveiralaura positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis AT lirolacruzmariajose positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis AT tagarroalfredo positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis AT alcobendasruedarosamaria positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis AT lopezlopezagustin positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis AT satrustegiaritziturrimiren positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis AT calvocristina positionstatementoninfectionscreeningprophylaxisandvaccinationinpediatricpatientswithrheumaticdiseasesandimmunosuppressivetherapiespart2infectionprophylaxis |